Guillaume Bouguéon

Guillaume Bouguéon

Auto-generated profile, based on publicly available information

Guillaume Bouguéon

Univ. Bordeaux, CNRS, INSERM, ARNA, UMR 5320, U1212

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BDBérangère Dessane
Bérangère Dessane
RSRawen Smirani
Rawen Smirani
GBGuillaume Bouguéon
Guillaume Bouguéon
Tina KaussTina Kauss
Tina Kauss
EREmeline Ribot
Emeline Ribot
SCSylvie Crauste-Manciet
Sylvie Crauste-Manciet
One of the greatest challenges in the field of biofabrication remains the discovery of suitable bioinks that satisfy physicochemical and biological requirements. Despite recent advances in tissue engineering and biofabrication, progress has been limited to the development of technologies using polymer-based materials. Here, we show that a nucleotide lipid-based hydrogel resulting from the self-assembly of nucleotide lipids can be used as a bioink for soft tissue reconstruction using injection or extrusion-based systems. To the best of our knowledge, the use of a low molecular weight hydrogel as an alternative to polymeric bioinks is a novel concept in biofabrication and 3D bioprinting. Rheological studies revealed that nucleotide lipid-based hydrogels exhibit suitable mechanical properties for biofabrication and 3D bioprinting, including i) fast gelation kinetics in a cell culture medium and ii) shear moduli and thixotropy compatible with extruded oral cell survival (human gingival fibroblasts and stem cells from the apical papilla). This polymer-free soft material is a promising candidate for a new bioink design.

7 April 2026 in Connective Tissue Research
Verified
Journal Article
Closed access
CDCamille Déchelette
Camille Déchelette
GBGuillaume Bouguéon
Guillaume Bouguéon
ANAdrien Naveau
Adrien Naveau
Gingival recession consists in irreversible exposure of the dental root surface to the oral environment,1 leading dental hypersensitivity and tooth loosening. This pathology affects more than two-t...

3 April 2026
Verified
Thesis
Closed access
GBGuillaume BouguéoN
Guillaume BouguéoN
La bioimpression 3D est une branche de l’ingénierie tissulaire actuellement en plein essor, cherchant à reproduire avec fidélité la microarchitecture complexe de tissus et organes. Malgré un large éventail de biomatériaux utilisés dans la formulation de bioencres, il s’avère essentiel de trouver une alternative aux biomatériaux naturels et synthétiques classiquement utilisés, permettant de mimer la matrice extracellulaire et de présenter des capacités d’impression de façon conjointe.Le présent travail met en avant, pour la première fois, les capacités de la molécule bioinspirée de type nucléolipide diC16dT à permettre la formulation d’une encre de bioimpression par extrusion. L’encre, formulée dans du milieu de culture cellulaire présentait des propriétés rhéologiques lui permettant d’être imprimée de façon continue. Il a également été possible d’y incorporer des fibroblastes gingivaux tout en maintenant leur viabilité cellulaire au sein des bioconstructions. Cette encre offre également plusieurs possibilités d’adaptation, notamment en terme de concentration en diC16dT et de milieux de culture en vue de répondre aux exigences d’autres types cellulaires. Enfin, des travaux préliminaires ont permis l’incorporation de liposomes dans la formulation de l’encre sans affecter ses capacités d’impression. Ceci permettra d’envisager la délivrance de substances actives ou d’éléments nutritifs au sein des bioimpressions, fonctionnalité des liposomes qui, à notre connaissance n’avait jamais été mise en valeur auparavant.

28 August 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GBGuillaume Bouguéon
Guillaume Bouguéon
AJArthur Jouvien
Arthur Jouvien
JBJean-Marc Bernadou
Jean-Marc Bernadou
AVArnaud Venet
Arnaud Venet
ABAude Berroneau
Aude Berroneau
FXFabien Xuereb
Fabien Xuereb
Idarubicine is a mainstay of the treatment strategy for hematological cancer. The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies. The aim of the present work is to establish the stability of idarubicin preparations diluted in polyolefin-type bags (Freeflex + ®) for intravenous administration in hematological clinical settings. Preparations were produced by diluting Zavedos® idarubicin in Freeflex + ® bags containing 0.9% sodium chloride (NaCl) or 5% dextrose (Dex) at concentrations of 0.04 mg/mL and 0.2 mg/mL. These preparations were stored at 5 ± 3 °C or 22 ± 3 °C. Three bags were prepared to evaluate each condition, for a total of 24 bags. To assess chemical stability, a stability-indicating high pressure liquid chromatography-ultraviolet/visible diode array detector assay was used. Samples were assayed on days D0, D1, D2, D7, D15, D22 and D30. A physical stability study was carried out on days D0, D15 and D30, looking for visible and sub-visible particles, measuring pH and osmolality. During the study, sample concentrations remained above 95% of the initial concentration, and no degradation products were detected. No color change or precipitation were observed with the naked eye. Sub-visible particles count remained below recommended limits. The pH and osmolality values remained unchanged from D0. This study demonstrates the stability of idarubicin, diluted to concentrations between 0.04 and 0.2 mg/mL in solutions of 0.9% NaCl and 5% Dex, stored at 5 ± 3 °C or 22 ± 3 °C for 30 days.